Description
Using our intelligently designed and intuitive dataset, you can quickly understand how Charles River Laboratories International, Inc. (CRL) is lobbying the U.S. government, how much they’re spending on it, and most importantly – the bills and specific issues on which they lobby.
Gain an informational edge with our Lobbying Data Intelligence. Perform analysis by company, lobbyist, lobbying firm, government agency, or issue.
For lobbying firms: understand your competitors. Understand who is registering with who. Gain insight on quarterly reports and specific issues other firms are lobbying on.
Our lobbying data is collected and aggregated from the U.S. Senate Office of Public Records from 1999-present and is updated on a regular basis. We utilize advanced data science techniques to ensure accurate data points are collected and ingested, match similar entities across time, and tickerize publicly traded companies that lobby.
Our comprehensive and advanced lobbying database is completed with all the information you need, with more than 1.6 million lobbying contracts ready-for-analysis. We include detailed information on all aspects of federal lobbying, including the following fascinating attributes, among much more:
1. Clients: The publicly traded company, privately owned company, interest group, NGO, or state or local government that employs or retains a lobbyist or lobbying firm.
2. Registrants (Lobbying Firms): Either the name of the lobbying firm hired by the client, or the name of the client if the client employs in-house lobbyists.
3. Lobbyists: The names and past government work experience of the individual lobbyists working on a lobbying contract. 3. General Issues: The general issues for which clients lobby on (ex: ENV – Environment, TOB – Tobacco, FAM – Family Issues/Abortion).
4. Specific Issues: A long text description of the exact bills and specific issues for which clients lobby on.
5. Bills Lobbied On: The exact congressional bills and public/private laws lobbied on, parsed from lobbying report specific issues (ex: H.R. 2347, S. 1117, Tax Cuts and Jobs Act).
6. Agencies Lobbied: The names of one or more of 250+ government agencies lobbied on in the contract (ex: White House, FDA, DOD).
7. Foreign Entities: The names and origin countries of entities affiliated with the client (ex: BNP Paribas: France).
Gain access to our highly unique and actionable U.S. lobbying database. Further information on LobbyingData.com and our alternative datasets and database can be found on our website, or by contacting [email protected].
Frequently Asked Questions
What is Charles River Laboratories International, Inc. (CRL) lobbying for?
Summary of Lobbying Data:
– Lobbying Firms: Bgr Government Affairs, Mcguirewoods Consulting (A Subsidiary Of Mcguirewoods Llp), Covington & Burling Llp
– General Issues: Animals, Pharmacy, Health Issues
– Specific Issues:
1. Provide strategic counsel and advocacy for issues related to the non-human primate supply chain for research and practical applications of invitro alternatives in research.
2. Work on the need for Limulus Amebocyte Lysate (LAL) product and synthetic products to be regulated similarity in terms of safety and effectiveness.
3. Provide strategic counsel and advocacy for issues related to the non-human primate supply chain for research and practical applications of invitro alternatives in research.
– Government Agencies: Natl Institutes of Health (NIH), Department of State (DOS), House of Representatives, Food & Drug Administration (FDA), Department of Health & Human Services (HHS), Senate, Natl Security Council (NSC)
One could infer that Charles River Laboratories International, Inc. is lobbying on issues related to the non-human primate supply chain and in vitro alternatives in research because they are likely a company that uses animals for testing and research purposes. The lobbying on the need for LAL regulation can also be linked to their work with animals, as LAL is a test for bacterial contamination commonly used in the testing of medical products and devices. Additionally, their lobbying efforts on pharmacy and health issues are likely tied to their work in the medical and pharmaceutical industry.
